C Kupfer. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisHealth Status IndicatorsHumansNational Institutes of Health (U.S.)Ophthalmology/trendsQuality of LifeRandomized Controlled Trials as Topic/trendsTechnology Assessment, BiomedicalUnited States
Year: 1996 PMID: 8956644 DOI: 10.1016/s0002-9394(14)70386-1
Source DB: PubMed Journal: Am J Ophthalmol ISSN: 0002-9394 Impact factor: 5.258